Skip to content
Contract signedUnited KingdomGoods

Capital Purchase of Genetic Screening Processor and Panthera Punch

Published
Published 3 June 2026

Overview

The Cardiff and Vale University Health Board have a requirement to replace the current Newborn Screening Analysers used for CHT and CF screening. The current equipment is at the end of life, as well as nearing discontinuation. Replacement is required with the newer version, the Revvity Genetic Service Processor (GSP) to ensure continuity of service provision, In addition to replacing the GSP, there is also a need to replace the current Panther multi puncher that is also at the very end of its lifespan

Key details

Country
United Kingdom
Status
Contract signed
Category
Goods
Procedure
Limited
Published
3 June 2026
Classification (CPV)
Medical equipmentsAnalysers

Award outcome

Awarded value
£511,496
Award date
16 March 2026
Winner
  • REVVITY (UK) LIMITED

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract

    3 June 2026

    View notice ↗

Contracting authority

  • NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

    Buyer

    Cardiff, United Kingdom

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Capital Purchase of Genetic Screening Processor and Panthera Punch — won by REVVITY (UK) LIMITED — Skim